A randomized control trial to test the effectiveness, feasibility, and acceptability of an education intervention promoting healthy lifestyle to reduce risk factors for metabolic syndrome, among office workers in Ethiopia.

Not Applicable

Active, not recruiting

• Conditions: Metabolic syndrome; Obesity; Diabetes; Hypertension; Cholesterol; Cardiovascular - Hypertension; Diet and Nutrition - Obesity; Metabolic and Endocrine - Diabetes; Public Health - Health promotion/education

• Registration Number: ACTRN12623000409673
• Lead Sponsor: ational Center for Epidemiology and Population Health, the Australian National University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-04-24
• Last Update Posted: 27 February 2024

Recruitment & Eligibility

• Status: Active, not recruiting
• Sex: All
• Target Recruitment: 226

Inclusion Criteria

Bank workers with age greater than or equal 18 years old and who fulfil at least one of the following National Cholesterol Education Program Adult Treatment Panel III (NCEP: ATPIII) metabolic syndrome criteria; Waist circumference >102 cm in men, > 88 cm in women, Triglycerides greater than or equal 150 mg/dl, HDL-cholesterol < 40 mg/dl in men and < 50 mg/dl in women, BP greater than or equal130/85 mmHg, fasting glucose greater than or equal110 mg/dl will be included in the study.

Exclusion Criteria

Bank workers who have at least one of the NCEP: ATP III metabolic syndrome criteria but with dietary restrictions and absolute contraindication for physical activity due to musculoskeletal, neurological, vascular, lung and cardiac problems, pregnant mothers, lactating mothers, those who have a plan to be pregnant within the intervention months and diagnosis of severe psychiatric disorders, significant cognitive impairment, and those who will not available throughout the program will be excluded from the study.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Obesity (waist circumference). which will be measured using a tape measure at the approximate midpoint between the lower margin of the last palpable rib and the top of the iliac crest or at the abdomen’s maximum extension. [ Baseline and 9 months after intervention commencement ];Blood pressure (BP). It will be measured using appropriate size sphygmomanometer. [ baseline and 9 months after intervention commencement. ];Biochemical markers. Which will be assessed by laboratory analysis of fasting plasma glucose level, blood plasma total cholesterol, high density lipoprotein cholesterol, triglyceride level, and low-density lipoprotein cholesterol.[ Baseline and 9 months after intervention commencement.]